-+ 0.00%
-+ 0.00%
-+ 0.00%

ONCOVITA GRANTED ORPHAN DRUG DESIGNATION FOR MVDELTAC IN MESOTHELIOMA BY THE EUROPEAN COMMISSION

Reuters·11/09/2026 14:32:34

Please log in to view news